Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Arnon

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2005
The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and beta 2-microglobulin-free HLA-G moleculesTsufit Gonen-Gross, Hagit Achdout, Tal I Arnon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2003
Enhanced recognition of human NK receptors after influenza virus infectionHagit Achdout, Tal I Arnon, Gal Markel, et al.
Immunity|April 17, 2020
Visualization of T Cell Migration in the Spleen Reveals a Network of Perivascular Pathways that Guide Entry into T ZonesAnne Chauveau, Gabriela Pirgova, Hung-Wei Cheng, et al.
Journal of Molecular Biology|July 16, 2008
The crystal structure of CHIR-AB1: a primordial avian classical Fc receptorTal I Arnon, Jens T Kaiser, Anthony P West, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2004
MHC class I-independent recognition of NK-activating receptor KIR2DS4Gil Katz, Roi Gazit, Tal I Arnon, et al.
Nature|March 10, 2001
Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cellsO Mandelboim, N Lieberman, M Lev, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2002
CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicityGal Markel, Niva Lieberman, Gil Katz, et al.
European Journal of Immunology|June 24, 2004
Recognition of Mycoplasma hyorhinis by CD99-Fc moleculeRoi Gazit, Hagai Rechnitzer, Hagit Achdout, et al.
Plos One|May 15, 2008
Harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapyTal I Arnon, Gal Markel, Ahuva Bar-Ilan, et al.
Plos One|May 5, 2015
Correction: harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapyTal I Arnon, Gal Markel, Ahuva Bar-Ilan, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2005
The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and beta 2-microglobulin-free HLA-G moleculesTsufit Gonen-Gross, Hagit Achdout, Tal I Arnon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2003
Enhanced recognition of human NK receptors after influenza virus infectionHagit Achdout, Tal I Arnon, Gal Markel, et al.
Immunity|April 17, 2020
Visualization of T Cell Migration in the Spleen Reveals a Network of Perivascular Pathways that Guide Entry into T ZonesAnne Chauveau, Gabriela Pirgova, Hung-Wei Cheng, et al.
Journal of Molecular Biology|July 16, 2008
The crystal structure of CHIR-AB1: a primordial avian classical Fc receptorTal I Arnon, Jens T Kaiser, Anthony P West, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2004
MHC class I-independent recognition of NK-activating receptor KIR2DS4Gil Katz, Roi Gazit, Tal I Arnon, et al.
Nature|March 10, 2001
Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cellsO Mandelboim, N Lieberman, M Lev, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2002
CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicityGal Markel, Niva Lieberman, Gil Katz, et al.
European Journal of Immunology|June 24, 2004
Recognition of Mycoplasma hyorhinis by CD99-Fc moleculeRoi Gazit, Hagai Rechnitzer, Hagit Achdout, et al.
Plos One|May 15, 2008
Harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapyTal I Arnon, Gal Markel, Ahuva Bar-Ilan, et al.
Plos One|May 5, 2015
Correction: harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapyTal I Arnon, Gal Markel, Ahuva Bar-Ilan, et al.
Pageof 10